December 22, 2021

HYPOCRETIN OREXIN

HYPOCRETIN (OREXIN ) deficiency in human narcolepsy HYPOCRETIN (OREXIN ) loss in Parkinson’s disease Neurons containing HYPOCRETIN (OREXIN ) project to multiple neuronal systems Behavioral correlates […]
December 22, 2021

TRYPTOPHAN HYDROXYLASE 2

TRYPTOPHAN HYDROXYLASE –2 controls brain serotonin synthesis TRYPTOPHAN HYDROXYLASE 2 (TPH2 ) gene variants associated with ADHD TRYPTOPHAN HYDROXYLASE –2 (TPH2 ) in disorders of cognitive […]
December 22, 2021

DYNORPHIN

DYNORPHIN 1–8 and DYNORPHIN 1–9 are ligands for the κ-subtype of opiate receptor Behavioral effects and in vivo degradation of intraventricularly administered DYNORPHIN-(1-13) and D-Ala2-DYNORPHIN-(1-11) in […]
December 22, 2021

GABA (γ-AMINOBUTYRIC ACID)

Free γ –AMINOBUTYRIC ACID in brain The action of γ –AMINOBUTYRIC ACID on cortical neurones γ –AMINOBUTYRIC ACID in brain: its formation from glutamic ACID Biochemical-physiology […]
December 22, 2021

HPA AXIS

The HPA axis is involved in the neurobiology of mood disorders and functional illnesses, including anxiety disorder, bipolar disorder, insomnia, posttraumatic stress disorder, borderline personality disorder, […]
January 21, 2022

GLYCATION

GLYCATION and diabetic complications Role of GLYCATION in aging Mechanisms of GLYCATION in atherogenesis The pathological implications of protein GLYCATION. GLYCATION products and the pathogenesis of […]
January 21, 2022

ANTI GLYCATIVE

ANTI‐GLYCATIVE and ANTI‐inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice ANTI-oxidative, ANTI–GLYCATIVE and ANTI-apoptotic effects of oleanolic acid in brain of […]
January 21, 2022

PROTEIN CARBONYLATION

PROTEIN CARBONYLATION PROTEIN CARBONYLATION in human diseases PROTEIN CARBONYLATION, cellular dysfunction, and disease progression Cell signaling by PROTEIN CARBONYLATION and deCARBONYLATION PROTEIN CARBONYLATION as a major […]